Skip to main content

endovascular aneurysm repair

Interview
12/18/2023
We spoke with Dr. Adam Beck to discuss how these organizations are working together to improve EVAR.
We spoke with Dr. Adam Beck to discuss how these organizations are working together to improve EVAR.
We spoke with Dr. Adam Beck to...
12/18/2023
Vascular Disease Management
Video
06/01/2022
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR initial case example using the Gore Active Control System.
Dr. Erin Moore discusses an EVAR...
06/01/2022
Vascular Disease Management
Case Report
11/21/2018
Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.
Patients treated with the lower-profile AFX Strata endograft have an increased risk of type III endoleak which may be treated with relining, according to a case report.
Patients treated with the...
11/21/2018
Vascular Disease Management
Interview
09/11/2018
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM, spoke about endovascular aneurysm repair at the 2018 International Symposium on Endovascular Therapy.
Frank J. Criado, MD, FACS, FSVM,...
09/11/2018
Vascular Disease Management
Case Report
03/21/2014
The authors report a successful resolution of a type 1A endoleak post endovascular repair of an abdominal aortic aneurysm 52-year-old male using transarterial N-butyl cyanoacrylate embolization.
The authors report a successful resolution of a type 1A endoleak post endovascular repair of an abdominal aortic aneurysm 52-year-old male using transarterial N-butyl cyanoacrylate embolization.
The authors report a successful...
03/21/2014
Vascular Disease Management
Clinical Editor's Corner
08/01/2012
On April 4, 2012, the FDA cleared Cook’s AAA fenestrated stent-graft for commercialization in the U.S. This is a customized design that must be constructed to the anatomical specifications of an individual patient.
On April 4, 2012, the FDA cleared Cook’s AAA fenestrated stent-graft for commercialization in the U.S. This is a customized design that must be constructed to the anatomical specifications of an individual patient.
On April 4, 2012, the FDA...
08/01/2012
Vascular Disease Management
Case Report
09/05/2008
Endovascular aneurysm repair (EVAR) has emerged as a routine and viable alternative in the treatment of abdominal aortic aneurysms (AAA). Its efficacy has been confirmed in many studies, and its role in the treatment of atherosclerotic...
Endovascular aneurysm repair (EVAR) has emerged as a routine and viable alternative in the treatment of abdominal aortic aneurysms (AAA). Its efficacy has been confirmed in many studies, and its role in the treatment of atherosclerotic...
Endovascular aneurysm repair...
09/05/2008
Vascular Disease Management
Review
09/05/2008
The treatment of abdominal aortic aneurysms (AAA) has changed significantly over the last several years since Parodi’s first description of an endoluminally placed infrarenal aortic stent graft. The continued evolution and increasing...
The treatment of abdominal aortic aneurysms (AAA) has changed significantly over the last several years since Parodi’s first description of an endoluminally placed infrarenal aortic stent graft. The continued evolution and increasing...
The treatment of abdominal...
09/05/2008
Vascular Disease Management